Marco Davila, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

MarcoLuisDavilaMDPhD

Oncology Tampa, FL

Hematologic Oncology

Associate Member

Overview of Dr. Davila

Dr. Marco Davila is an oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Memorial Sloan-Kettering Cancer Center. He received his medical degree from Duke University School of Medicine and has been in practice 13 years. Dr. Davila accepts several types of health insurance, listed below. He is one of 393 doctors at Memorial Sloan-Kettering Cancer Center and one of 144 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology.

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFELLOWSHIP
  • New York Presbyterian Hospital
    New York Presbyterian HospitalRESIDENCY
  • Duke University School of Medicine
    Duke University School of MedicineMEDICAL_SCHOOL
  • Texas Christian UniversityOTHER_TRAINING

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2015 - 2021
  • TN State Medical License
    TN State Medical License 2013 - 2015
  • NY State Medical License
    NY State Medical License 2006 - 2017
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Young Physician-Scientist Award ASCI Council, 2014
  • Amos Medical Faculty Development Program Scholar American Society of Hematology, 2012
  • TRiO Achiever Award Texas Christian University, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • CARs move to the Fast Lane  
    Davila ML and Papetrou E, Molecular Therapy, 1/1/2014
  • Chimeric Antigen Receptors for the Adoptive T Cell Therapy Of Hematologic Malignancies  
    Davila, ML, Bouhassira DC, Park JH, Curran KJ, Smith EL, Pegram HJ, and Brentjens R., International Journal of Hematology, 1/1/2014
  • Chimeric Antigen Receptor Therapy for Chronic Lymphocytic Leukemia: What are the Challenges?  
    Davila ML, Brentjens R, Hematol Oncol Clin North Am, 1/1/2013
  • Join now to see all

Abstracts/Posters

  • Human CD83 Targeted Chimeric Antigen Receptor T Cell for the Prevention of Graft Versus Host Disease and Treatment of Myeloid Leukemia
    Marco L. Davila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
    Marco L. Davila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • MDSC Suppression of CAR T Cells Can be Reduced By Targeted Signaling Disruption
    Marco L. Davila, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Phase 1 Studies Assessing the Safety and Clinical Activity of Multiple Doses of a NKG2D-Based CAR-T Therapy, Cyad-01, in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Aged CAR T Cells Exhibit Enhanced Cytotoxicity and Effector Function but Shorter Persistence and Less Memory-like Phenotypes 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Atara Biotherapeutics to Host CAR T Breakfast Teach-in on November 29, 2018
    Atara Biotherapeutics to Host CAR T Breakfast Teach-in on November 29, 2018January 03, 2019
  • Anixa Biosciences : Appoints Leading Researchers in Immuno-Oncology to Its Scientific Advisory Board
    Anixa Biosciences : Appoints Leading Researchers in Immuno-Oncology to Its Scientific Advisory BoardOctober 11, 2018

Grant Support

  • The Adoptive Transfer Of Gene-Modified T Cells As A Cell Therapy For LymphomaNational Cancer Institute2010–2011

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment